Buscar por Materia Cancer

Ir a una fecha de inicio:
Mostrando resultados 37 a 56 de 97 < Anterior   Siguiente >
Vista previaFecha de publicaciónFecha de CreaciónTítulo
Ets transcription factors in intestinal morphogenesis, homeostasis and disease.pdf.jpg2008-Ets transcription factors in intestinal morphogenesis, homeostasis and disease
Epidemiology and molecular biology of gastrointestinal stromal tumors -GISTs- a population-based study in the South of Switzerland, 1999-2005.pdf.jpg2008-Epidemiology and molecular biology of gastrointestinal stromal tumors -GISTs- a population-based study in the South of Switzerland, 1999-2005
Protein methylation, a new mechanism of p53 tumor suppressor regulation.pdf.jpg2008-Protein methylation, a new mechanism of p53 tumor suppressor regulation
Loss of a reporter gene for green fluorescent protein during tumor progression suggests the recruitment of host.pdf.jpg2008-Loss of a reporter gene for green fluorescent protein during tumor progression suggests the recruitment of host cells in rats with experimentally induced colon cancer
Int J cancer 2008.pdf.jpg15-nov-2008-Targeting the methionine cycle for melanoma therapy with 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin
Receptorbinding cancer antigen expressed on SiSo cells RCAS1 a novel biomarker.pdf.jpg2009-Receptor-binding cancer antigen expressed on SiSo cells (RCAS1), a novel biomarker in the diagnosis and prognosis of human neoplasia
Melatonin modulates microfilament phenotypes in epithelial cells implications.pdf.jpg2009-Melatonin modulates microfilament phenotypes in epithelial cells, implications for adhesion and inhibition of cancer cell migration
Focal adhesion kinase and cancer.pdf.jpg2009-Focal adhesion kinase and cancer
The transcription factor Fos a Janustype regulator in health and disease.pdf.jpg2009-The transcription factor Fos, a Janus-type regulator in health and disease
Annexins as disease modifiers.pdf.jpg2010-Annexins as disease modifiers
MCM proteins as diagnostic and prognostic tumor markers in the clinical setting.pdf.jpg2010-MCM proteins as diagnostic and prognostic tumor markers in the clinical setting
An immunohistochemical study of cyclooxygenase-2 expression in canine multicentric lymphoma.pdf.jpg2011-An immunohistochemical study of cyclooxygenase-2 expression in canine multicentric lymphoma
Heron-Milhavet-26-651-662-2011.pdf.jpg2011-Akt1 and Akt2: Differentiating the aktion
Shah-27-567-579-2012.pdf.jpg2012-High mobility group A1 and cancer: Potential biomarker and therapeutic target
Zhu-27-257-261-2012.pdf.jpg2012-BAG3: a new therapeutic target of human cancers?
Romero-Camarero-27-157-170-2012.pdf.jpg2012-New models towards assessing anti-cancer therapeutics
Park-27-197-207-2012.pdf.jpg2012-High MET copy number and MET overexpression: Poor outcome in non-small cell lung cancer patients
Mittelbronn-28-749-758-2013.pdf.jpg2013-Expression of integrins αvß3 and αvß5 and their ligands in primary and secondary central nervous system neoplasms
Beaman-29-293-304-2014.pdf.jpg2014-The extended ppGalNAc-T family and their functional involvement in the metastatic cascade
Tsujiuchi-29-313-321-2014.pdf.jpg2014-Lysophosphatidic acid receptors in cancer pathobiology